ICC Makes Strategic Investment in Disruptive Biosynthesis Research -- CFN Media

He leading agency and financial media network dedicated to the North American cannabis industry, announces the publication of an article covering biosynthesis and International Cannabis Corp.’s recent biotechnology investment. Biosynthesis is the process of manipulating simple substances to produce the complex molecules found within living organisms. Biosynthetic engineering, as applied to cannabis, means single cell organisms are programmed to synthesize the enzymes for the metabolic pathway that generates cannabinoids from sugars - promising new technology with the potential to shake up the nascent cannabis industry. Guided by an understanding of the potential the technology offers, International Cannabis Corp. (CSE: WRLD.U)(FWB: 8K51)(OTC: WLDCF) announced on April 8th a USD $1.2 million strategic investment in Biotii Technologies Corp. a leading private biotechnology company actively pursuing genetically engineered microorganisms that express cannabinoid profiles identical to those found in nature - at a fraction of the cost of current production methods with more consistent quality and a greatly reduced carbon footprint. Recent advancements in the areas of gene editing, in-silico protein modeling, and semi-automated high throughput robotics has enabled Biotii to expedite its molecular biology research, allowing the company to spearhead into large-scale production with a wide portfolio of intellectual property. This evolving portfolio is expected to consist of synthetic cannabinoids, designer enzymes, proprietary enzyme pathways, and GMO microorganisms. Traditional cultivation of cannabis plants for the purpose of extracting cannabidiolic acid (CBDA), THC and CBD is a time, labour, and resource intensive endeavor which often results in lower yields. By 2020, the Biotii team plans to establish processes to mass-produce CBD/THC in quantities of hundreds of metric tons per annum boasting stable and consistent yields, pharmaceutical grade purities, and the lowest production costs in the cannabis space.